Chemours stock up 2% on outlook despite Q3 miss
Chemours (CC) reported Q3 earnings of $0.21 per share, missing estimates by $0.06, with revenue at $1.5B, up 3% YoY. Shares rose 2% on outlook despite the miss. Q4 revenue is expected to decline 5-10%, with adjusted EBITDA between $160M-$185M. Full-year 2026 revenue growth is projected at 2%, with adjusted EBITDA between $775M-$800M.
How this was made
The 30-second read
Why it matters
Traders can update expectations using the provided Q4 consolidated revenue decline range (-5% to -10% sequentially), Q4 adjusted EBITDA range ($160M-$185M), and full-year 2026 revenue and adjusted EBITDA guidance, plus the 2026 net leverage target below 4.2x.
Market read
This is a company-specific earnings and guidance update that can drive near-term re-rating, despite the headline Q3 miss.
What to watch
Thermal & Specialized Solutions EBITDA fell 30% due to weaker North American stationary air conditioning aftermarket sales, which could be a drag if it persists beyond Q4.
Background
Chemours reported Q3 results with adjusted EPS and revenue below analyst estimates, while highlighting strength in Titanium Technologies and Advanced Performance Materials.
Ticker impact
Chemours (CC) reported Q3 adjusted EPS of $0.21 and revenue of $1.5B, missing consensus, while guiding Q4 EBITDA to $160M-$185M.
Near-term support likely as traders focus on the Q4 and full-year EBITDA ranges and net leverage target, but upside may be capped by the reported EPS and revenue misses.
The article provides fresh, decision-relevant guidance ranges (Q4 EBITDA, FY revenue and EBITDA, and 2026 net leverage) plus the specific miss magnitudes for EPS and revenue, which can drive positioning after-hours and into the next session.
Market effects
Chemicals investors may recalibrate expectations for pricing versus volume dynamics in TiO2 and performance materials end markets based on Chemours’ segment commentary.
Limited direct regional read-through beyond US-listed chemical peers, since the article centers on company-specific guidance and segment performance.
Global demand signals are referenced (data center and semiconductor end markets), but the actionable content is primarily Chemours’ own outlook.
Counterpoint
The 2% stock pop may fade if the market interprets the Q3 miss and the 2% volume decline as evidence that pricing gains are not fully offsetting demand softness.
Key entities
- companyChemours Company
US-listed global chemistry company reporting Q3 results and issuing Q4 and full-year 2026 guidance.
- personDenise Dignam
Chemours President and CEO quoted on segment performance and demand drivers.
